Susquehanna International Group
ACET icon

Susquehanna International Group’s Adicet Bio ACET Stock Holding History

Susquehanna International Group’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$360K Buy
+52,900
New +$396K ﹤0.01% 10457
2023
Q3 		– Sell
-656
Closed -$25.5K – 11917
2023
Q2 		$25.5K Sell
656
-144
-18% -$12.7K ﹤0.01% 11574
2023
Q1 		$73.7K Sell
800
-394
-33% -$49.4K ﹤0.01% 11503
2022
Q4 		$171K Sell
1,194
-1,106
-48% -$276K ﹤0.01% 10341
2022
Q3 		$523K Sell
2,300
-631
-22% -$160K ﹤0.01% 8358
2022
Q2 		$685K Buy
2,931
+1,318
+82% +$289K ﹤0.01% 7475
2022
Q1 		$515K Buy
+1,613
New +$371K ﹤0.01% 8890
2020
Q1 		– Sell
-140
Closed -$23K – 10151
2019
Q4 		$23K Buy
+140
New +$70.9K ﹤0.01% 9475

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Susquehanna International Group's ACET Position: Q4 2025 in Review

Susquehanna International Group sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 2,523 shares — an estimated $32.7K sold.

Susquehanna International Group first reported a position in ACET in Q4 2019 and held it in 20 quarters. The position peaked at $1.13M in Q1 2021. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • Susquehanna International Group reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 2,523 Adicet Bio shares in Q4 2025, an estimated $32.7K.
  • Susquehanna International Group first reported a position in Adicet Bio in Q4 2019 and held it in 20 quarters.
  • Susquehanna International Group's Adicet Bio position peaked at $1.13M in Q1 2021.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.